REGN Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
$475.00 -1.36 (-0.29%)
As of 04/09/2021 15:59:59 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Large cap
GICS sector: Health Care
Industry: Biotechnology
Index country: USA
Country of incorporation: USA
IPO date: 03/01/2001
Outstanding shares: 105,282,929
Average volume: 930,064
Market cap: $50,027,289,373
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
CUSIP: 75886F107
ISIN: US75886F1075
Sedol: 2730190
Valuation (See tab for details)
PE ratio: 14.24
PB ratio: 4.48
PS ratio: 5.89
Return on equity: 31.86%
Net income %: 41.35%